Vladimir has more than 30 years of experience in biomedical R&D, with roles spanning from research scientist at the George Washington University School of Medicine, Fogarty Fellow at the National Cancer Institute NIH, Bethesda, Maryland, to multiple senior roles at Quintiles (IQVIA), including VP and Head of Global Operations Center, Global leadership team member, Regional VP for CEE and MENA, partner and co-founder of VIARES Academy, a clinical trial informatics company, CEO at SanaClis, a full service global specialty CRO.

With over 25 years in the pharmaceutical industry, Dr. Artem Andrianov is a leading expert in clinical data quality and biostatistics. As the CEO of Cyntegrity, he specializes in data-driven risk management in clinical trials. His academic background includes a Ph.D. in Mathematical Modelling and an Executive MBA. Dr. Andrianov co-founded Cyntegrity in 2013, focusing on advancing RBQM. His specialized knowledge spans Spirometry, ECG, Oncology, ePROs, and clinical data management. Committed to making clinical trials safer and more reliable, Dr. Andrianov is a key figure in the evolution of RBQM.

Dr. Baris Erdogan has over 25 years in IT, with 15 years in healthcare. He specializes in AI and ML for data-driven healthcare, particularly in drug development, Clinical Research, and Real-World Evidence (RWE). As CEO of Evideep, a Swiss data and technology company, he also serves as an Assistant Professor at Istinye University, lecturing on data science in healthcare. Additionally, he is the Deputy Director of Istinye University Artificial Intelligence Research and Application Center.

An influential and data-driven executive professional with a robust background in the Pharmaceutical and Public Health sectors, bringing a unique blend of expertise in leading digital transformation initiatives and leveraging data to guide corporations through complex business changes. Recognized as a thought leader/industry expert in the data, digital health, and AI ecosystem, excelling at understanding industry trends and developing strategic perspectives to guide digital health and AI partnerships and investments. High-level analytical skills and deep expertise in drug development, clinical, safety and regulatory processes, data management, digital innovation, and governance.

Kamila Novak holds MSc in molecular genetics. She has been involved in clinical research since 1995, having worked in various positions in pharma and CROs. Since 2010, she has been working as an independent consultant and incorporated in 2019. Her business activities include auditing, SME consulting for QMS establishment and process improvements, medical writing, and training. Kamila is a certified Lead Auditor for ISO 9001, ISO 31000, ISO 13485, and ISO 15189, a trained auditor for ISO 14155, cGMP-QMS, and GXP. She is a member of the EMWA, the DIA, the CPD UK, the SQA, the Association for GXP Excellence, the WMDO, and other professional societies. In the SQA, she is the Chair of the Beyond Compliance Specialty Section.